Background Childhood eczema is very common and can have substantial impact on quality of life. One of the main treatments is topical corticosteroids, but these are often underused by parents and carers for reasons that include concerns about safety. Objectives To explore understandings and concerns about topical corticosteroids among parents and carers of children with eczema who had posted messages in online forums. Methods A qualitative study of messages and their resultant discussions about topical corticosteroids for childhood eczema posted by parents and carers on two U.K.-based discussion forums. Results Ninety-five forum users involved in 27 discussions relating to topical corticosteroid use in childhood eczema were identified dating from 2003 to 2015. Analysis of discussions highlighted three themes: (i) diverse beliefs about the use of topical corticosteroids; (ii) uncertainty and confusion about using and applying topical corticosteroids; and (iii) seeking to resolve conflicting advice received offline and advice on navigating health services. People expressed a general sense of cautiousness about topical corticosteroids, wide-ranging concerns and considerable confusion, for instance about potency or safe duration of use. They sought advice from other forum users who they perceived as having experiential expertise. Some posts attempted to reassure that topical corticosteroids were safe if used correctly, but overall the discussions seemed likely to amplify existing concerns. Conclusions Given the prevalence of concerns and uncertainties about topical corticosteroids, signposting parents and carers of children with eczema towards detailed, credible information about how to use topical corticosteroids safely would be beneficial. In the absence of such information, parents and carers are likely to turn to online discussion forums where, although much useful support and advice can be found, the credibility of advice cannot be assured.
• There was widespread confusion, particularly around the potency of different products, duration of use and safety, for instance of use on the face.
• Carers value the experiential advice and support of online forum users to try to resolve offline knowledge deficits after consultation or confusion following conflicting offline advice.
What are the clinical implications of this work?
• This study highlights that people seeking eczema information in online forums are likely to find advice with potentially both negative and positive impacts.
• Widespread confusion expressed online suggests the need for clear, consistent advice about topical corticosteroids, including signposting parents and carers towards reliable, evidence-based resources.
• Further research is needed to find effective ways of communicating with carers and to develop resources to support them if questions arise after consultation.
Eczema is very common, affecting > 20% of children aged 5 years or younger at some point. 1, 2 It can have a substantial impact on quality of life and cause significant distress to children and their families because of rashes, itching and sleep disturbance. 3 Research from secondary care suggests that the impact on quality of life in children with severe eczema is second only to that of cerebral palsy, with greater impact than for asthma or diabetes. 4 The main treatments for eczema are emollients and topical corticosteroids, but consensus guidelines suggest that poor treatment adherence is the main cause of treatment failure. 5 Reasons for poor adherence include child refusal, therapy being time intensive or incomplete understanding of treatments. 6, 7 Despite professional consensus that topical corticosteroids are safe if used correctly (Table 1) , research has found widespread 'steroid phobia' among parents and carers, forming a barrier to effective eczema care. [8] [9] [10] Although steroid phobia has been recognized for some years, there is relatively little qualitative research exploring the nature of parents' and carers' concerns about topical corticosteroids.
Of the qualitative studies that have touched on views of topical corticosteroids, one found that people with eczema said they would prefer to manage eczema without having to depend on conventional treatments, although they felt it was impossible to control the eczema without them, considering them to be a 'necessary evil'. 11 Others have found that patients and carers sometimes receive conflicting advice regarding their safe use from different health professionals. 12, 13 Another qualitative study found that parents had unmet information needs, including questions about sideeffects of topical corticosteroids and finding alternatives. 14 Further qualitative research that seeks to explore parents' and carers' understandings and concerns about using topical corticosteroids to help to manage their child's eczema would enable better understanding of the barriers to their use. The internet has revolutionized our relationship with information. In 2015, 86% of households in Great Britain had internet access and 78% of people accessed the internet every day or nearly every day. 15 Online platforms are increasingly being used to communicate with others who have similar health issues. 16 Online forums are discussion sites that allow users to communicate their personal experiences and engage in interaction with other individuals, through the medium of asynchronous written communication. These forums may provide qualitative researchers with a rich and valuable source of primary, naturalistic data about users' perspectives and experiences of a particular health issue, and may enable analysis of discourses taking place within the online setting. [17] [18] [19] There Topical corticosteroids should be used only on areas of active atopic eczema (redness or flare-ups), or eczema that has been active within the past 48 h, which may include areas of broken skin. Emollients should be used continuously for maintenance (preventing flares) Potency of topical corticosteroid should be matched to eczema severity, e.g. mild potency for mild disease, moderate potency for moderate disease, and potent topical corticosteroids for short-term use in severe eczema Start treatment as soon as signs of a flare appear and continue for 48 h after symptoms subside Use is generally in short bursts of 3-5 days to gain control, and for up to 2 weeks in moderate-to-severe disease On the face and neck, particularly in children, start with a mild topical corticosteroid, except for short-term use (3-5 days) of moderate topical corticosteroids for severe flares Very potent preparations in children should be used only under specialist dermatological supervision. Potent topical corticosteroids in children under 12 months should be used only with specialist dermatological supervision If flares are frequent (two or three per month) consider topical corticosteroids for two consecutive days per week as maintenance treatment once the eczema has been controlled has been an increase in qualitative research seeking to analyse these data on a wide range of health-related conditions. [20] [21] [22] [23] Qualitative research has started to explore the potential impacts of using online forums. Several domains through which patients' online interactions can impact positively and negatively on health have been described, including finding information, feeling supported, affecting behaviour (others' experiences can influence behaviour change) and experiencing health services (navigating services, asking questions of health professionals). 24 Others have highlighted the importance of online forums in redressing offline knowledge deficits and for modelling behaviours from others in the self-management of long-term conditions. They also highlight the permanence of internet communication, providing a wealth of information available for future forum users. It is therefore particularly pertinent to explore the nature of information being shared in this way. 25 Qualitative studies of discussions about eczema in online forums can allow valuable insight into forum users' perspectives and experiences, which may complement existing qualitative research. This study aims to explore the understandings and concerns about topical corticosteroids among parents and carers of children with eczema who have posted messages on online forums.
Patients and methods
This qualitative study sought to explore messages (and their resultant discussions) about topical corticosteroids posted by parents and carers of children with eczema to two U.K.-based discussion forums.
Data retrieval
A scoping review of online resources for parents and carers of children with eczema was conducted by one author (E.J.T.) in August 2015 to identify relevant forums. One eczema forum was chosen as the most consistently active forum based in the U.K. At the time of the search it had 5828 postings on 1233 eczema topics (including 1050 postings to the 'eczema in babies and children' section) dating back to 2003. The scoping review also highlighted discussions related to eczema on various parenting forums. A U.K.-based, general parenting forum with over 14 million visits per month was also chosen to allow a diverse range of perceptions and understandings about topical corticosteroid use in childhood eczema to be explored.
The researcher familiarized herself with these forums, enabling a search strategy to be devised for each forum. For the parenting forum the internal search function was employed to search for discussions on 'topical steroids'. For the eczema forum, the section on 'babies and children' was searched for all discussion threads relating to 'topical steroids'. Searches were conducted in November 2015. To ensure comprehensive and systematic representation of forum discussions, the first 100 search results for each forum were reviewed. Data were collected until saturation was achieved (no new themes emerged). All discussions relevant to the research question were copied into Microsoft Word verbatim, assigned a unique ID, and then exported to the qualitative data management software NVivo (version 10; QSR International, Doncaster, Australia) for analysis.
Ethical considerations
Approval was granted by the University of Southampton Faculty of Medicine Ethics Committee in November 2015 (reference 17457). Debate surrounds the use of online forum messages for the purposes of qualitative data analysis, particularly about perceptions of privacy and the extent to which the messages are considered to be in the public domain. 16, 19, 26, 27 The approach adopted in this study follows the British Psychological Society guidelines, 28 which consider online forum messages to be located within the public domain, provided that no forum registration is required by the researcher to view them. This approach has been widely used in other studies. [20] [21] [22] The online forums involved in this study are freely available to the public and open access (i.e. not password protected); people contributing to the forum discussions can therefore be considered as giving their implicit consent for open access to these discussions. Following the ethics committee's guidance and to protect the anonymity of the data, the forums have not been identified and data excerpts have been paraphrased with any identifiable information removed. All authors agreed on the adapted paraphrased quotations prior to submission.
Data analysis
An inductive thematic analysis was conducted to enhance understanding about patient and carer views about topical corticosteroids for children with eczema. 29, 30 Each discussion was read several times and relevant posts coded line by line by one author (E.J.T.). Codes were derived inductively from the data and grouped together to produce an initial coding frame. From this a detailed coding manual was created to ensure transparent and systematic coding of the data. Codes and theme/subtheme definitions were discussed with, and iteratively developed by, the research team (E.J.T., M.S. and I.M.) to offer diverse inferences and interpretation of the data. Using NVivo enabled a detailed audit trail to be maintained.
Results
Forum searches yielded 27 discussions relating to topical corticosteroid use in childhood eczema (17 discussions from the parenting forum and 10 from the eczema forum). These discussions involved 95 forum users and dated from 2003 to 2015. The discussions were conversational, generally supportive in nature and similar in both forums, although the eczema forum appeared to have greater site moderation (i.e. an employee or forum user who responds to some of the comments or removes spam).
Analysis of parents' and carers' discussions about topical corticosteroids highlighted three themes: (i) diverse beliefs about the use of topical corticosteroids; (ii) uncertainty and confusion about using and applying topical corticosteroids; and (iii) seeking to resolve conflicting advice received offline and advice on navigating health services. These themes are explored in detail below. Selected quotes to illustrate each theme and subtheme are presented in Table 2 . All quotes are labelled with a participant ID and type of forum (E, eczema forum; P, parenting forum).
Diverse beliefs about the use of topical corticosteroids
A range of beliefs were expressed in the forum discussions including beliefs about perceived efficacy, potential side-effects and correct usage of topical corticosteroids. A sense of cautiousness about using topical corticosteroids for treating childhood eczema was commonly expressed. Many viewed topical corticosteroids as 'strong', 'harsh' or 'unnatural' products. Some forum users saw topical corticosteroids as an ineffective way of managing their child's eczema due to the seemingly transient relief of eczema flare-ups that they provided. Terms such as 'rebound' or 'withdrawal' were used, suggesting an overlap with the terminology and concepts of addiction.
A dominant belief about the effects of topical corticosteroids was that they cause the skin to thin or fade, or reference was made to generalized notions of 'skin damage'. Many forum users expressed great anxiety about applying creams that could potentially cause permanent harm to their child's skin. For some forum users, concerns about skin thinning seemed to be influenced by the advice they received from their health professional and other forum users, reinforcing the view that the risks of topical corticosteroids outweighed the benefits.
Other perceived negative effects of topical corticosteroids were also explored. In one discussion, some forum users believed that topical corticosteroids could have an effect on mood and behaviour, but other users felt that this was unlikely and more associated with anabolic steroid use. This highlights the potential for confusion with other 'steroid' products that are very different from topical corticosteroids.
Although there appeared to be a general sense of caution, positive views about topical corticosteroid use were also expressed. In particular, some expressed a view that topical corticosteroids were safe and effective if used correctly and that using topical corticosteroids provided an increased sense of control over their child's eczema flare-ups. Underpinning these more positive views seemed to be the belief that more damage would be done to their child's skin by not trying to control eczema with topical corticosteroids, as this could lead to infection and greater skin damage from scratching. Some forum users offered advice to others, for instance about having to taper off steroid use rather than just stop to prevent more flare-ups. Others believed (and advised other forum users) that it is important to continue to treat an eczema flareup for a few days after it has visibly calmed down.
Uncertainty and confusion about using and applying topical corticosteroids
The forums seemed to be used by parents and carers asking questions about duration of use and where and when to use creams, and expressing confusion about the strength/potency of different creams. A common concern expressed in the forums was about potential overuse of topical corticosteroids. Uncertainties about the amount of cream to use per application and about using continuous applications but on different or subsequent flare-ups were expressed. This seemed to be influenced by doubts about when to stop and how to stop using topical corticosteroids successfully.
Some forum users expressed uncertainty about where on the body topical corticosteroids could be safely used and questioned the suitability of topical corticosteroids for babies and young children and on sensitive areas of the body such as the face. Other forum users were reassured about using topical corticosteroids on their children's faces if they perceived the creams to be low-strength corticosteroids. The perceived potency and variety of different topical corticosteroid creams seemed to be another source of uncertainty in the online discussions. A common representation in the forum discussions was that a higher-percentage topical corticosteroid cream is more potent, regardless of the active ingredient or type of steroid (i.e. a 2Á5% mild topical corticosteroid is viewed as more potent than a 0Á1% very potent topical corticosteroid).
Seeking to resolve conflicting advice received offline and advice on navigating health services Another source of concern for parents and carers revolved around their experiences of receiving conflicting advice about topical corticosteroids in terms of duration, dosage, tapering and safety (sensitive areas, side-effects) from different health professionals. People also talked about their experiences of receiving conflicting advice about specific topical corticosteroid treatments from health professionals compared with product information leaflets and medical websites, in terms of suitability for young children and directions for use. These experiences of conflicting advice contributed to forum users' accounts of uncertainty and caution around topical corticosteroid use, and seemed to create doubts about the trustworthiness of some professional advice. Forum users sought to resolve these conflicts by asking others for their advice in the hope of getting a 'clear answer' from other parents with experiential expertise.
Related to this, some posts discussed experiences of health services and responded to others' concerns with advice about how to navigate services, for instance reflecting on differing responses from different health professionals, or suggesting requesting dermatology referral from their general practitioner.
Discussion
Analysis of online discussions about topical corticosteroid use in childhood eczema highlighted three themes: (i) diverse We used [potent topical corticosteroid] for about a month and a half in the end. Sadly it only worked on the days we were putting it on, but I decided to stop because I was so worried about the side-effects it could have. Luckily it didn't damage his skin at all, but I was super worried and for ages I asked every dermatologist we saw to have a look just to be sure! (Parenting forum, P11-6) My baby started getting eczema over the last month or so. My GP suggested [leave-on emollient] and I am using loads of it, but I don't think it's doing anything. I asked the GP if there's anything else I can try because I thought it might be worth trying a mild steroid cream but my doctor advised against it because the risks (skin thinning) outweigh the benefits. (Eczema forum, P7-1) Topical corticosteroids affect mood P1: I was using a [mild topical corticosteroid] on my 11-month-old boy for a few months. During this time he seemed to act more aggressively than usual. I am not using the creams anymore and he seems to have calmed down -has anyone else experienced this? P2: Are you worried that this steroid may be affecting his behaviour in the same way that, say, anabolic steroids can? They are very different. P3: Strong hydrocortisone creams can affect the pituitary gland so I think it's possible they can affect mood, they can also affect the adrenal gland, but I think that is quite rare. I do know people who have had withdrawal symptoms from using [potent topical steroid], which included feeling sick, trembling and anxiety, so there is clearly some affect on mood. (Parenting forum, P3) Topical corticosteroids are safe if used correctly My 6-year-old daughter gets really upset about her eczema. We try to take breaks from the steroids so only use it for a week or so and then stop for a few days. You're unlikely to get any skin thinning as long as you are off the steroids as often as you are using them. (Eczema forum, P8-2) My baby girl got eczema all over her body when she was only a few months old. We are using a mild steroid cream, but I've always thought that it will only cause problems like skin thinning and things like that if you use strong steroids for a long period of time. It's better to get the itching under control so it's OK to use it for a short time in a low dose. (Eczema forum, P7-2) My son's had eczema since he was a few months old. We took him to see a specialist at the hospital, and she gave us a stronger cream (2Á5%) and told us to use it with emollient and bath oil. The doctor reassured us that it's safe even for babies and better to react to a flare-up with the cream than to let him itch and scratch, which can further damage the skin. We've been given a strong steroid diluted in petroleum jelly. Apparently they use this type of topical steroid in a lot of top children's hospitals. We only use it when needed, for as little time as possible. It's really important to taper your child off steroid creams or else they'll get flare-ups when they come off it. (Parenting forum, P11-4) P2: Am I supposed to use the [mild topical corticosteroid] on red skin and then stop as soon as the skin looks better? I heard somewhere that you should keep using it for a couple of days after the skin looks better. P3: It [mild topical corticosteroid] will work quicker on new eczema so best to use it as soon as you spot any new patches. It's also a good idea to use it for 1 or 2 days after the skin looks better to make sure all the layers of skin have healed and not just the top layer. (Eczema forum, P4) (continued) Our dermatologist gave us a steroid called [moderate topical corticosteroid] ointment to use on our 6 month old. I've been putting it all over her body and face for the past 5 days. We were told to use it as long as the skin is red (it is always red). No one told us not to use it for too long, or to avoid her face. I'm really worried about it as I don't want to damage her skin. Do you think it's OK to use it on the face? (Eczema forum, P5-1) We always use steroid creams for flare-ups. It's usually pretty good at clearing the patches but you need different strength creams for different parts of the body. Our dermatologist's given us a 1% strength to use on the face, and beliefs about the use of topical corticosteroids; (ii) uncertainty and confusion about using and applying topical corticosteroids; and (iii) seeking to resolve conflicting advice received offline and advice on navigating health services. A general sense of cautiousness about topical corticosteroids and a wide range of specific concerns were expressed in the forums. There was relatively little awareness about how to access advice regarding best practice in topical corticosteroid use for childhood eczema. Many forum users expressed concerns about the perceived short-term or transient effectiveness of topical corticosteroids, with linked concerns about 'rebound' or 'withdrawal' effects. Many forum users also spoke about potential side-effects of topical corticosteroid use such as skin thinning. These findings are consistent with previous research, which highlighted that fears of skin thinning are a common cause for concern around topical corticosteroid use, [8] [9] [10] and that the concept of 'control' rather than 'cure' of eczema is challenging for parents.
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Many carers appeared to bring their uncertainties to the forum, asking questions about safety and duration of use and where and when to use creams, and expressing confusion about the strength/potency of different products. This is consistent with a recent metasynthesis exploring how patient online communities contribute to supporting self-management of long-term conditions, which found that people reach out to online communities because of an unmet offline need for information and/or emotional support. 25 Parents also shared their experiences of receiving conflicting advice from different health professionals, or conflicting advice from professionals compared with product information leaflets and trying to resolve this through asking advice from other forum users. While a general sense of caution about regularly using medicines has been found for many conditions, 31 the specific uncertainties about topical corticosteroids highlight a need for more detailed information about the different types and strengths of topical corticosteroids. They also highlight a need for consistent advice from health professionals about safe and effective use, including signposting to accessible high-quality information, in order to enable self-management if questions arise after the consultation or clinic visit. Forum users appeared to value the social support and group identity from online interaction with other parents and carers with similar experiences. It has been observed in online forums for other conditions that users appear to favour the experiential knowledge of perceived 'expert patients' with experience of the condition over the presumed expert knowledge of health professionals. 25 We found a similar phenomenon of forum users seeking detailed health information from 'expert parents', particularly when they had received conflicting advice in the offline world. This may suggest that the general public no longer consider medical expertise as something that exists solely in health professionals. 32 Online communities allow users to navigate collective knowledge, which is created through the lived experiences of peers, in accessible language and at their convenience. As such, this collective, experiential knowledge of fellow lay people can be viewed as a more useful resource than the medical knowledge of health professionals. 25 A potential disadvantage of online forums is that the content of messages could be misleading or inaccurate, particularly with regards to medical information, and the potential for both negative and positive impacts from such online support has been highlighted by others. 24, 32 Forum users are unable to judge the expertise of people giving medical advice on online forums and there is no guarantee that a person claiming to report an experience has actually had that experience. We found examples of useful advice in our data about continuing to treat eczema flare-ups after they had visibly calmed down, and forum users clearly valued the opportunity to ask questions of other parents. We also found examples of potentially unhelpful advice about skin damage and skin thinning, and seemingly commercially driven advice that promoted expensive, nonevidence-based eczema treatments. The overall impression was of information that would be likely to amplify existing concerns about topical corticosteroids and, in particular, concerns about skin thinning. Nevertheless, online forums function as a powerful site of community for their users, and such group identification, as defined by social identity theory, 33 is beneficial to well-being and behaviour. Previous qualitative research on health-related online forums has highlighted the important role that they play in providing the opportunity to receive social support and to learn from and model others' lived experiences. 20, 21, 34 Bandura's Social Learning Theory 35 proposes that people learn from one another by observing, imitating and modelling others' behaviours and the outcomes of those behaviours. Being able to see how others cope with and manage a particular condition can help to validate illness experiences and negate potential offline frustrations. 25 This study highlights a novel and useful way of exploring people's concerns on a health topic, which can complement primary qualitative research. It is possible that the people who accessed the forums explored in this study had more extreme views and more difficult experiences than others. Data were retrospectively collected so it was not possible to ask parents to expand on or clarify their postings. Being able to clarify and explore further the parents' and carers' understandings and concerns of topical corticosteroids may have generated richer data that would have enabled a more in-depth qualitative analysis. With more time we might have explored other aspects relating to the use of online forums for eczema, for instance exploring emotional support provided within forums.
In conclusion, parents and carers of children with eczema need clear, consistent and detailed information about how to use topical corticosteroids safely in case questions arise after general practitioner or dermatologist consultation. Given the prevalence of concerns about potential adverse effects of topical corticosteroids, it would seem prudent to signpost parents and carers towards convenient, consistent, evidence-based information to ensure that the potential negative impacts of seeking (unsubstantiated) medical advice online are minimized. In the absence of such information they are likely to turn to online discussion forums as their sole resource where, although much useful support and advice can be found, some is of questionable validity.
